University of Queensland

About: University of Queensland is a education organization based out in Brisbane, Queensland, Australia. It is known for research contribution in the topics: Population & Poison control. The organization has 51138 authors who have published 155721 publications receiving 5717659 citations. The organization is also known as: UQ & The University of Queensland.

Chemoselective catalytic conversion of glycerol as a biorenewable source to valuable commodity chemicals

Abstract: New opportunities for the conversion of glycerol into value-added chemicals have emerged in recent years as a result of glycerol's unique structure, properties, bioavailability, and renewability. Glycerol is currently produced in large amounts during the transesterification of fatty acids into biodiesel and as such represents a useful by-product. This paper provides a comprehensive review and critical analysis on the different reaction pathways for catalytic conversion of glycerol into commodity chemicals, including selective oxidation, selective hydrogenolysis, selective dehydration, pyrolysis and gasification, steam reforming, thermal reduction into syngas, selective transesterification, selective etherification, oligomerization and polymerization, and conversion of glycerol into glycerol carbonate.

Fabrication of Graphene/Polyaniline Composite Paper via In Situ Anodic Electropolymerization for High- Performance Flexible Electrode

Abstract: Freestanding and flexible graphene/polyaniline composite paper was prepared by an in situ anodic electropolymerization of polyaniline film on graphene paper. This graphene-based composite paper electrode, consisting of graphene/polyaniline composite sheets as building blocks, shows a favorable tensile strength of 12.6 MPa and a stable large electrochemical capacitance (233 F g(-1) and 135 F cm(-3) for gravimetric and volumetric capacitances), which outperforms many other currently available carbon-based flexible electrodes and is hence particularly promising for flexible supercapacitors.

The Future of Peptide‐based Drugs

Abstract: The suite of currently used drugs can be divided into two categories - traditional 'small molecule' drugs with typical molecular weights of 5000 Da that are not orally bioavailable and need to be delivered via injection. Due to their small size, conventional small molecule drugs may suffer from reduced target selectivity that often ultimately manifests in human side-effects, whereas protein therapeutics tend to be exquisitely specific for their targets due to many more interactions with them, but this comes at a cost of low bioavailability, poor membrane permeability, and metabolic instability. The time has now come to reinvestigate new drug leads that fit between these two molecular weight extremes, with the goal of combining advantages of small molecules (cost, conformational restriction, membrane permeability, metabolic stability, oral bioavailability) with those of proteins (natural components, target specificity, high potency). This article uses selected examples of peptides to highlight the importance of peptide drugs, some potential new opportunities for their exploitation, and some difficult challenges ahead in this field.